The retinoid burst in hepatic stellate cell mediated liver fibrosis
肝星状细胞介导的肝纤维化中的类维生素A爆发
基本信息
- 批准号:9033667
- 负责人:
- 金额:$ 3.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-01-01 至 2017-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdipocytesAlcoholsAmericanAreaBasic ScienceBiologyCarbon TetrachlorideCellsCellular biologyCessation of lifeChronicCicatrixCirrhosisCollagenDataDevelopmentDiseaseEnzymesEventExtracellular Matrix ProteinsFibronectinsFibrosisFosteringFoundationsFutureGene Expression RegulationGenerationsGoalsHealth Care CostsHealthcare SystemsHepatic FibrogenesisHepatic Stellate CellHepatitis CHepatologyHumanIn VitroIndividualInjuryInvestigationKnockout MiceKnowledgeLaboratoriesLigandsLigationLinkLipidsLiverLiver CirrhosisLiver FibrosisLiver diseasesMediatingMediator of activation proteinMedicalMetabolismMicroRNAsMolecularMorbidity - disease rateMyofibroblastNational Research Service AwardsOrganellesPathway interactionsPatientsPhosphorylationPhysiciansPlayProcessProductionPropertyQuality of lifeRegulationResearchResearch PersonnelRetinoidsRiskRodent ModelRoleScientistSignal TransductionSiteSmooth Muscle Actin Staining MethodTGF Beta Signaling PathwayTimeTrainingTransforming Growth Factor betaTretinoinUnited StatesVitamin AWound Healingbasebile ductcareercareer developmentclinically significantdesignexperiencefibrogenesisin vivoinjuredknowledge baseliver injurymortalitymouse modelnon-alcoholic fatty livernovel strategiesprematurepreventpublic health relevancereceptorresponseretinaldehyde dehydrogenaseskillsstellate celltherapeutic targettumorigenic
项目摘要
DESCRIPTION (provided by applicant): Cirrhosis represents the liver's response to chronic injury. In the US, the most common causes of cirrhosis include nonalcoholic fatty liver disease (NAFLD), alcohol, and hepatitis C virus infection and it is estimated that over 10 million people have cirrhosis. Many of these patients suffer from debilitating sequela, resulting in decreased quality of life and placing a heavy burden on the healthcare system. The Rockey Laboratory is currently elucidating the mechanisms controlling hepatic fibrosis with the ultimate goal of developing anti- fibrotic therapies to abrogate or reverse cirrhosis in at-risk individuals. Extensive investigation points to the activated hepatic stellate cell (HSC) as the primary cell typ responsible for mediating the fibrogenic response. This cell is also the predominant storage site for vitamin A in the body. However, during liver injury, and the development of fibrosis and cirrhosis, HSCs become activated and lose their vitamin A stores from specialized organelles known as lipid droplets. Retinoic acid (RA), the biochemically active derivative of vitamin A, serves as a mediator of the retinoid signaling cascade, a pathway known to have profibrotic and pro-tumorigenic properties. Further, preliminary data indicate that RA signaling plays an important role on molecular pathways important in TGFß signaling, a pathway critically linked to stellate cell activation and fibrogenesis supporting the postulate that depletion of vitamin A from
lipid droplets leads to release of RA within the cell, which in turn has critical molecular effectsin the cell. The vitamin A depletion event is termed herein the "retinoid burst". The molecular basis for the loss of vitamin A from HSC lipid droplets is also unknown. Given this information, this application proposes the following hypothesis: 1) Liver injury results in RA release from lipid droplets during the retinoid burst causing the activation of HSCs, 2) RA release from lipid droplets leads to lipid droplet depletion seen in activated HSCs, 3) A specific enzyme, retinaldehyde dehydrogenase 1 (RALDH1) is responsible for RA release during the retinoid burst and 4) RA release during the retinoid burst is the trigger for HSC activation and blockade of RA release will maintain HSCs in a quiescent state. The aims of this proposal are to characterize the retinoid burst in activated HSCs, to determine the regulation of and downstream effects of the retinoid burst, and to understand the role of RALDH1 in regulating RA signaling during in vivo liver injury. This research will delineate the retinoid burst in injured HCs and determine the events connecting retinoid metabolism with TGFß signaling. All evidence suggests this cascade is potent and a target that can be harnessed for the development of anti-fibrotic agents to abrogate hepatic fibrosis and cirrhosis in at-risk individuals. The training portion of this NRSA proposal is designed to build upon the candidate's research skills and foster her training as a physician-scientist performing high-impact basic research with potential to better patients in need of medical ingenuity. This training plan is the foundation on which the applicant will establish an independent research career in the field of liver fibrosis.
描述(申请人提供):肝硬变代表肝脏对慢性损伤的反应。在美国,导致肝硬变的最常见原因包括非酒精性脂肪性肝病(NAFLD)、酒精和丙型肝炎病毒感染,据估计,超过1000万人患有肝硬变。其中许多患者患有衰弱的后遗症,导致生活质量下降,并给医疗保健系统带来沉重负担。罗基实验室目前正在阐明控制肝纤维化的机制,最终目标是开发抗纤维化疗法,以消除或逆转高危个体的肝硬变。广泛的研究表明,活化的肝星状细胞(HSC)是介导纤维化反应的主要细胞类型。这个细胞也是体内维生素A的主要储存场所。然而,在肝损伤、纤维化和肝硬化的发展过程中,HSC被激活,失去了被称为脂滴的特殊细胞器中的维生素A储存。维甲酸(RA)是维生素A的生物化学活性衍生物,是维甲酸信号通路的中介物,该通路具有促纤维化和促肿瘤的特性。此外,初步数据表明,RA信号在转化生长因子B信号通路中的重要分子通路中发挥重要作用,这一通路与星状细胞激活和纤维化形成密切相关,支持维生素A从
脂滴导致维甲酸在细胞内释放,进而在细胞内产生关键的分子效应。维生素A的耗竭事件在这里被称为“类维甲酸爆发”。从HSC脂滴中损失维生素A的分子基础也是未知的。鉴于这些信息,本应用提出以下假设:1)肝脏损伤导致在视黄醇爆裂期间从脂滴中释放RA导致HSC激活,2)从脂滴中释放RA导致激活的HSC中的脂滴耗尽,3)一种特定的酶,视黄醛脱氢酶1(RALDH1)负责在视黄醇爆裂期间释放RA,4)在视黄醇爆裂期间RA释放是HSC激活的触发因素,阻止RA释放将使HSC保持静止状态。本研究的目的是确定活化的HSC中的维甲酸爆发的特征,确定维甲酸爆发的调节和下游效应,并了解RALDH1在体内肝损伤过程中调节RA信号的作用。这项研究将描绘受损的HCS中的维甲酸的爆发,并确定维甲酸代谢与转化生长因子?信号有关的事件。所有证据表明,这种级联反应是有效的,可以作为开发抗纤维化药物的靶点,以消除高危个体的肝纤维化和肝硬变。该NRSA提案的培训部分旨在以候选人的研究技能为基础,并培养她作为一名内科科学家的培训,执行具有高影响力的基础研究,有可能改善需要医疗独创性的患者。这项培训计划是申请者在肝纤维化领域建立独立研究生涯的基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Loretta L. Jophlin其他文献
Provider Attitudes and Practices for Alcohol Screening, Treatment and Education in Patients with Liver Disease: a Survey from the AASLD ALD SIG.
提供者对肝病患者进行酒精筛查、治疗和教育的态度和做法:来自 AASLD ALD SIG 的调查。
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:12.6
- 作者:
G. Im;Jessica L. Mellinger;A. Winters;E. Aby;Z. Lominadze;J. Rice;M. Lucey;J. Arab;A. Goel;Loretta L. Jophlin;C. Sherman;R. Parker;Po;D. Devuni;S. Sidhu;Winston Dunn;G. Szabo;A. Singal;V. Shah - 通讯作者:
V. Shah
Stress-Induced Takotsubo Cardiomyopathy After Transjugular Intrahepatic Portosystemic Shunt
经颈静脉肝内门体分流术后应激诱发的 Takotsubo 心肌病
- DOI:
10.14309/crj.0000000000000377 - 发表时间:
2020 - 期刊:
- 影响因子:0.7
- 作者:
Bernadette Lamb;Benjamin Arbeiter;N. Bhogal;John Anderson;Loretta L. Jophlin - 通讯作者:
Loretta L. Jophlin
Sinusoidal Dilatation and Peliosis Hepatis
正弦扩张和紫癜性肝炎
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
Loretta L. Jophlin;V. Shah;Douglas A. Simonetto - 通讯作者:
Douglas A. Simonetto
Ectopic Esophageal Sebaceous Glands
- DOI:
10.1016/j.cgh.2020.11.034 - 发表时间:
2022-04-01 - 期刊:
- 影响因子:
- 作者:
Loretta L. Jophlin;Christopher P. Hartley;David A. Katzka - 通讯作者:
David A. Katzka
Loretta L. Jophlin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Loretta L. Jophlin', 18)}}的其他基金
Interaction of the Microtubule Cytoskeleton and Perilipin-2 Regulates Hepatic Lipid Droplets - a Potential Therapeutic Target for Fatty Liver Disease
微管细胞骨架和 Perilipin-2 的相互作用调节肝脂滴 - 脂肪肝疾病的潜在治疗靶点
- 批准号:
10596083 - 财政年份:2021
- 资助金额:
$ 3.44万 - 项目类别:
Interaction of the Microtubule Cytoskeleton and Perilipin-2 Regulates Hepatic Lipid Droplets - a Potential Therapeutic Target for Fatty Liver Disease
微管细胞骨架和 Perilipin-2 的相互作用调节肝脂滴 - 脂肪肝疾病的潜在治疗靶点
- 批准号:
10375465 - 财政年份:2021
- 资助金额:
$ 3.44万 - 项目类别:
The retinoid burst in hepatic stellate cell mediated liver fibrosis
肝星状细胞介导的肝纤维化中的类维生素A爆发
- 批准号:
8909992 - 财政年份:2016
- 资助金额:
$ 3.44万 - 项目类别:
Interactions between TGFbeta and retinoid signaling in cardiac development
TGFbeta 和类视黄醇信号在心脏发育中的相互作用
- 批准号:
7541574 - 财政年份:2008
- 资助金额:
$ 3.44万 - 项目类别:
Interactions between TGFbeta and retinoid signaling in cardiac development
TGFbeta 和类视黄醇信号在心脏发育中的相互作用
- 批准号:
7689941 - 财政年份:2008
- 资助金额:
$ 3.44万 - 项目类别:
相似国自然基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
- 批准号:81970721
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
New development of cellular regeneration therapy in jaw bone using stem cells derived from adipocytes jaw bone
利用颌骨脂肪细胞来源的干细胞进行颌骨细胞再生治疗的新进展
- 批准号:
23K16058 - 财政年份:2023
- 资助金额:
$ 3.44万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A novel mechanism of insulin resistance mediated by uric acid metabolism in adipocytes
脂肪细胞尿酸代谢介导胰岛素抵抗的新机制
- 批准号:
23K10969 - 财政年份:2023
- 资助金额:
$ 3.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Hypertrophic adipocytes as biophysical mediators of breast cancer progression
肥大脂肪细胞作为乳腺癌进展的生物物理介质
- 批准号:
10751284 - 财政年份:2023
- 资助金额:
$ 3.44万 - 项目类别:
Development of adipocytes for gene therapy that avoids cellular stress due to overexpression of therapeutic proteins
开发用于基因治疗的脂肪细胞,避免因治疗蛋白过度表达而造成的细胞应激
- 批准号:
23H03065 - 财政年份:2023
- 资助金额:
$ 3.44万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Functional analysis of bitter taste receptors in adipocytes and hepatocytes
脂肪细胞和肝细胞中苦味受体的功能分析
- 批准号:
23K05107 - 财政年份:2023
- 资助金额:
$ 3.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of mechanisms for conversion of adipocytes to cancer-associated fibroblasts in osteosarcoma microenvironment
阐明骨肉瘤微环境中脂肪细胞转化为癌症相关成纤维细胞的机制
- 批准号:
23K19518 - 财政年份:2023
- 资助金额:
$ 3.44万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Study on UCP-1 independent metabolic regulation by brown adipocytes
棕色脂肪细胞对UCP-1独立代谢调节的研究
- 批准号:
23K18303 - 财政年份:2023
- 资助金额:
$ 3.44万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
NKA/CD36 signaling in adipocytes promotes oxidative stress and drives chronic inflammation in atherosclerosis
脂肪细胞中的 NKA/CD36 信号传导促进氧化应激并驱动动脉粥样硬化的慢性炎症
- 批准号:
10655793 - 财政年份:2023
- 资助金额:
$ 3.44万 - 项目类别:
The mechanisms of the signal transduction from brown adipocytes to afferent neurons and its significance.
棕色脂肪细胞向传入神经元的信号转导机制及其意义。
- 批准号:
23K05594 - 财政年份:2023
- 资助金额:
$ 3.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Characterizing breast cancer invasion and proliferation when co-aggregated with adipocytes in multicellular spheroids created with a custom bioreactor to augment cell-cell connectivity.
当与多细胞球体中的脂肪细胞共聚集时,表征乳腺癌的侵袭和增殖,该多细胞球体是用定制生物反应器创建的,以增强细胞间的连接。
- 批准号:
10334113 - 财政年份:2022
- 资助金额:
$ 3.44万 - 项目类别: